Related Experiment Videos
[Interstitial curietherapy in penile carcinoma. Preliminary study]
A J Chaudary1, R L Bhavalat, J N Kulkarni
1Department of radiation oncology, Tata Memorial Hospital, Bombay, Inde.
Summary
Iridium-192 brachytherapy effectively treated penis carcinoma in eight patients, achieving excellent local control and cosmetic outcomes. No patients developed groin lymph node metastasis after treatment.
Area of Science:
- Oncology
- Radiation Oncology
- Urologic Oncology
Context:
- Penile carcinoma is a rare malignancy with varying treatment approaches.
- Brachytherapy using Iridium-192 offers a localized treatment option for penile cancer.
- Understanding treatment outcomes is crucial for optimizing patient management.
Purpose:
- To report the outcomes of penile carcinoma treated with Iridium-192 interstitial brachytherapy.
- To evaluate local tumor control, cosmetic results, and regional lymph node status.
Summary:
- Eight patients with penile carcinoma (T1-T3) underwent Iridium-192 implant brachytherapy.
- Four patients had N0 groin status, and four had N1-2A (all with negative fine needle aspiration cytology).
- Six patients achieved complete local control with good cosmetic results; one had local failure salvaged by amputation; none developed groin metastasis.
Impact:
- Iridium-192 brachytherapy demonstrates efficacy in achieving local control for penile cancer.
- The technique offers good cosmetic results, potentially preserving penile function.
- This approach may help prevent the development of regional lymph node metastasis.